PLEASANTVILLE, Iowa — Zach Mecham has heard politicians demand that Medicaid recipients work or lose their benefits. He also has run into a jumble of Medicaid rules that effectively prevent many people with disabilities from holding full-time jobs. “Which is it? Do you want us to work or not?” he said. Mecham, 31, relies on…
By KIM BELLARD News flash: America is not a very happy place these days. No, I’m not talking about the current political divide (which is probably more accurately described as a chasm), at least not directly. I’m referring to the latest results from the World Happiness Report, which found that the U.S. has slid to…
A month before 23andMe’s bankruptcy filing, CEO Anne Wojcicki had a fully financed proposal to take the genetic testing company private. The financing fell apart, and a series of alternative proposals by Wojcicki did not result in a deal. The post Anne Wojcicki Had a Fully Financed Plan to Take 23andMe Private. Then It Fell…
President Donald Trump selected Susan Monarez — the current acting director of the Centers for Disease Control and Prevention — to lead the agency going forward. This nomination replaces one that the White House withdrew on March 13, after it became clear that physician and former Republican congressman Dave Weldon would not receive enough Senate…
PBGH is now offering its advisory services to any purchaser. These services help employers fulfill their fiduciary responsibility, understand their data and more. The post PBGH Offers Advisory Services to Support Employers’ Fiduciary Responsibilities appeared first on MedCity News.
This brief examines a proposed rule that seeks to change how ACA plans would cover gender affirming care services. If finalized the rule could lead insurers to drop coverage or shift costs to individuals and states, making access to gender affirming care more difficult.
Uncover the hidden costs holding payers back and explore innovative strategies to enhance transparency, accuracy, and cost savings in payment integrity—join industry experts for this insightful discussion.
Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. The post Novo Nordisk Bets $200M on Triple-Targeting Drug for…
In November 2024, CMS finalized a 2.83% decrease in the physician fee schedule conversion factor, a key aspect of payment rates under the Medicare program, resulting in a 2.93% decrease in overall payments to physicians and other clinicians. Congress has not yet enacted legislation to address this payment cut, which went into effect on January…
En un soleado día de semana en Atlanta, un pequeño grupo de personas se reunió para realizar una manifestación frente a la sede de un sindicato. Al evento, organizado por Nikema Williams, representante demócrata en el Congreso nacional, asistieron miembros del sindicato y también trabajadores federales recientemente despedidos, entre ellos Ryan Sloane. “Me despidieron a…